BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson’s Disease

Disease outcomes are heterogeneous in Parkinson’s disease and may be predicted by gene variants. This study investigated if the BDNF rs6265 single nucleotide polymorphism (SNP) is associated with differential outcomes with specific pharmacotherapy treatment strategies in the “NIH Exploratory Trials...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neurotherapeutics
Egile Nagusiak: Fischer, D. Luke, Auinger, Peggy, Goudreau, John L., Cole-Strauss, Allyson, Kieburtz, Karl, Elm, Jordan J., Hacker, Mallory L., Charles, P. David, Lipton, Jack W., Pickut, Barbara A., Sortwell, Caryl E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2020
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7851242/
https://ncbi.nlm.nih.gov/pubmed/33215284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-020-00965-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak